Table 2.
Consistency of P53 expression between preoperative biopsy and final pathology.
Preoperative biopsy | Final pathology | ||
---|---|---|---|
Total (n=1186, overall agreement: 83.8%, kappa: 0.624) | |||
P53wt | P53abn | Total | |
P53wt | 718 (60.5%) | 109 (9.2%) | 827 (69.7%) |
P53abn | 83 (7.0%) | 276 (23.3%) | 359 (30.3) |
Total | 801 (67.5%) | 385 (32.5%) | 1186 (100%) |
D&C or Pipelle biopsy (n=652, overall agreement: 79.4%, kappa: 0.539) | |||
P53wt | P53abn | Total | |
P53wt | 367 (56.3%) | 76 (11.7%) | 443 (67.9%) |
P53abn | 58 (8.9%) | 151 (23.2%) | 209 (32.1%) |
Total | 425 (65.2%) | 227 (34.8%) | 652 (100%) |
Hysteroscopic biopsy (n=534, overall agreement: 89.1%, kappa: 0.735) | |||
P53wt | P53abn | Total | |
P53wt | 351 (65.7%) | 33 (6.2%) | 384 (71.9) |
P53abn | 25 (4.7%) | 125 (23.4%) | 150 (28.1%) |
Total | 376 (70.4%) | 158 (29.6%) | 534 (100%) |
P53abn, P53 abnormality; P53wt, P53 wild-type.